“…Triazene compounds (TZCs) are characterized by the diazoamine group (N = N-N) (Moore, Robinson, 1986), which accounts for their biological properties (Marchesi et al, 2007). They have a broad pharmacological versatility: antibacterial (Horner et al, 2008;Domingues et al, 2010;Ombaka, Muguna, Gichumbi, 2012;Tizotti et al, 2016), antifungal (Ombaka, Muguna, Gichumbi, 2012), antileukemic (Matheson et al, 2004;Domingues et al, 2010;Bonmassar et al, 2013;Tizotti et al, 2016), and synthetic nuclease (Domingues et al, 2010). Dacarbazina® and Temozolomida® are examples of TZC compounds widely used in the clinical treatment of various malignancies (Bonmassar et al, 2013).…”